Prostate Cancer Diagnosis Pathway: 2024 Update

Anwar Padhani

A. Padhani

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Cancer Screening Molecular Tools

Fengting Yan

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

Ana Aparicio

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Whole-Body MRI: Past, Present, and Future

Houston Methodist

N. Gupta

Updates in the Treatment and Management of Bladder Cancer

Integrity CE

M. Galsky, B. Guercio

AUA Advanced Prostate Cancer Guidelines: 2023 Update

Robert Dreicer

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

Testosterone Suppression and Recovery in Patients With Advanced Pros…

Benjamin L. Maughan

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

SIR 2023 Conference Coverage

N. Kothary

ASCO® 2024 Summary: "Prostate Cancer Highlights"

2024 ASCO® Annual Meeting Insights Hub

N. Reizine, K. Tawagi

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers